Clal invests in Arcadian Networks

Clal Industries and Investments said Sunday it has invested $20m. in New York-based wireless broadband provider Arcadian Networks.

By AVI KRAWITZ
September 4, 2006 10:04

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Clal Industries and Investments said Sunday it has invested $20m. in New York-based wireless broadband provider Arcadian Networks. The company's investment follows the $40m. raised by Arcadian through Goldman Sachs and Gilo Ventures in April, when it started operations. Since then, Arcadian said it has introduced the first IP-based, private network and turn-key carrier services. The Clal investment will allow Arcadian to accelerate the sales, marketing and build-out of its data and voice communication network and associated telecommunication carrier services and solutions in the US .

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS